Beyond Air, Inc. (XAIR) Reports In-Line Q3 EPS, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
Beyond Air® Reports Fiscal Third Quarter 2025 Financial Results and Provides Corporate Update
February 10, 2025 4:05 PM ESTRevenues increased 34% compared to the previous quarter ended September 30, 2024; and exceeded $1 million
Received CE Mark for LungFit PH® in Europe and Market Authorization in Australia; international shipments to commence later this year
Conference call at 4:30 p.m. ET today, February 10th
GARDEN CITY, New York, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (Beyond Air or the Company), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve... More
